Scarica l'app Stockscreener
702.75
3.11%
-22.59
Pre-mercato:
727.84
25.09
+3.57%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché REGN Giù?
Forum
Previsione
Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie
Seizert Capital Partners LLC Has $45.14 Million Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
FDA Hands Regeneron Two Eylea HD Nods in One Day - BioSpace
Regeneron’s Eylea franchise boosted by pair of FDA approvals - Yahoo Finance
United States AMD Drug Market 2025: Get Exclusive Data | Top 5 - openPR.com
Intrust Bank NA Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Raymond James Adjusts PT on Regeneron Pharmaceuticals to $800 From $723, Keeps Outperform Rating - MarketScreener
Nomura Asset Management Co. Ltd. Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Rockefeller Capital Management L.P. Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Meridian Wealth Management LLC Lowers Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Why analysts raise outlook for Regeneron Pharmaceuticals Inc. (RGO) stockQuarterly Profit Review & Capital Efficiency Focused Strategies - newser.com
How Regeneron Pharmaceuticals Inc. (RGO) stock responds to job market shiftsMarket Volume Report & Advanced Swing Trade Entry Plans - newser.com
Stocks to Watch : Nvidia, Kulicke & Soffa, Regeneron - MarketScreener
Regeneron (REGN) Gains FDA Approval for Eylea HD Injection - GuruFocus
Regeneron Gets FDA Approval for Eylea to Treat Macular Edema - MarketScreener
Regeneron gets FDA nod for Eylea in macular edema treatment - Seeking Alpha
FDA Approves Eylea HD Injection from Regeneron (REGN) for Eye Conditions - GuruFocus
FDA approves EYLEA HD for retinal vein occlusion with extended dosing - Investing.com Canada
Regeneron stock rises as EYLEA HD gets FDA approval for new indication - Investing.com Canada
Regeneron Announces FDA Approval of EYLEA HD® for Retinal Vein Occlusion with New Dosing Options - Quiver Quantitative
Regeneron (NASDAQ: REGN) secures FDA approval for EYLEA HD in RVO with 8-week option and monthly dosing - Stock Titan
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected - simplywall.st
Why Regeneron Pharmaceuticals Inc. (RGO) stock is favored by hedge funds2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
What does recent volatility data suggest for Regeneron Pharmaceuticals Inc.IPO Watch & Risk Managed Investment Signals - newser.com
How currency fluctuations impact Regeneron Pharmaceuticals Inc. stockMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
Regeneron (REGN) Gains EU Approval for Expanded Use of Libtayo - GuruFocus
Regeneron gets EU nod for expanded approval of Libtayo (REGN:NASDAQ) - Seeking Alpha
Regeneron Pharmaceuticals Gets European Commission's Approval for Expanded Indication for Libtayo - MarketScreener
European Commission Approves the Pd-1 Inhibitor Libtayo of Regeneron Pharmaceuticals, Inc - MarketScreener
Can a trend reversal in Regeneron Pharmaceuticals Inc. lead to recoveryWeekly Investment Summary & Low Volatility Stock Recommendations - newser.com
REGN: European Approval for Regeneron's Libtayo in Skin Cancer T - GuruFocus
Regeneron (REGN) EC Approves Libtayo as First Adjuvant CSCC Immunotherapy, 68% Risk Cut - Stock Titan
How Regeneron Pharmaceuticals Inc. stock responds to policy changesMarket Volume Summary & Weekly High Conviction Ideas - newser.com
United States Bispecific T-cell Engagers (BiTEs) Market Size, - openPR.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Raiffeisen Bank International AG - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by ARS Investment Partners LLC - MarketBeat
How strong is Regeneron Pharmaceuticals Inc. stock balance sheetJuly 2025 Big Picture & Safe Entry Point Identification - newser.com
Can Regeneron Pharmaceuticals Inc. stock weather global recessionStop Loss & Growth Focused Investment Plans - newser.com
Why Regeneron Pharmaceuticals Inc. (RGO) stock is listed among top recommendationsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Citigroup Inc. - MarketBeat
Feds Look to 'False Certification' FCA Strategy - Law360
Semanteon Capital Management LP Sells 1,123 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
How Regeneron’s FDA Approvals and Recent Price Jump Impact Its 2025 Valuation - simplywall.st
Universal Beteiligungs und Servicegesellschaft mbH Has $55.94 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Ex-Dividend Reminder: CenterPoint Energy, Regeneron Pharmaceuticals and LeMaitre Vascular - Nasdaq
SG Americas Securities LLC Has $8.42 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What data driven models say about Regeneron Pharmaceuticals Inc.’s futureJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com
PNC Financial Services Group Inc. Cuts Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Bedell Frazier Investment Counselling LLC Reduces Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Drug-maker Regeneron plans $2B facility upstate, following Trump’s pharma tariffs - Crain's New York Business
Citizens Financial Group Inc. RI Acquires 1,871 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Is Regeneron Pharmaceuticals (REGN) One of the Best Gene-Editing Stocks to Buy According to Hedge Funds? - Finviz
0.33%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):